Keros Therapeutics CFO Keith Regnante Resigns, Effective Aug. 3; VP Finance Annita Tanini Named Interim Principal Financial Officer

Benzinga Newsdesk www.benzinga.com Neutral 93.2%

Neg 0% Neu 93.2% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/1664710/000166471026000038/kros-20260717.htm

Comments

No comments yet. Be the first!